Thus, Nrf2 inhibitors have been suggested as adjuvant therapies to sensitize cancers with high expression of Nrf2 [13] or as treatment options of chemo- and radio-resistant forms of cancer [14]. The gene discussed is NFE2L2; the disease is cancer.